Memory and depressions

Zhurnal Vysshei Nervnoi Deyatelnosti Imeni I.P. Pavlova

Volumn 56, Issue 4, 2006, Pages 556-570

  Grigoryan, G A ^a  

^a INSTITUTE OF HIGHER NERVOUS ACTIVITY AND NEUROPHYSIOLOGY   (Russian Federation)

Author keywords

Depression; Dopamine; Emotions; Frontal cortex; Hippocampus; Learning; Memory; n.accumbens; Noradrenaline; Reinforcement; Serotonin; Stress

Indexed keywords

ANIMAL; BRAIN; DEPRESSION; HUMAN; MEMORY; MEMORY DISORDER; METABOLISM; PHYSIOLOGY; REVIEW;

ANIMALS; BRAIN; DEPRESSION; HUMANS; MEMORY; MEMORY DISORDERS;

EID: 33750632865     PISSN: 00444677     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (100)

1. Russian source
2. Russian source
3. Russian source
4. Russian source
5. Russian source
6. Albert P.R., Lemonde S. 5-HT1A receptors, gene repression, and depression: guilt by association // Neuroscientist. 2004. V. 10. No 6. P. 575-593.
7. Anisman H., Matheson K. Stress, depression, and anhedonia: Caveats concerning animal models // Neurosci. Biobehav. Rev. 2005. V. 29. No 4-5. P. 525-546.
8. Austin M.P., Mitchell P., Goodwin G.M. Cognitive deficits in depression: possible implications for functional neuropathology // Br. J. Psychiatry. 2001. V. 178. P. 200-206.
9. Bayer T.A., Schramm M., Feldmann N., Knable M.B., Falkai P. Antidepressant drug exposure is associated with mRNA levels of tyrosine receptor kinase B in major depressive disorder // Prog. Neuropsychopharmacol. Biol. Psychol. 2000. V. 24. P. 881-888.
10. Beck A.T. The core problem in depression: the cognitive triad // Depression: Theories and Therapies / Ed. Masserman J.H. N.Y.: Grune and Stratton, 1970. P. 47-55.
11. Berger A.K., Fratiglioni L., Forsell Y., Winblad B., Backman L. The occurrence of depressive symptoms in the preclinical phase of AD: a population-based study // Neurology. 1999. V. 53. No 9. P. 1998-2002.
12. Berridge K.C., Robinson T.E. What is the role of dopamine in reward: hedonic impact, reward learning, or incentive salience? // Brain Res. Brain Res. Rev. 1998. V. 28. No 3. P. 309-369.
13. Blum K., Braverman E.R., Holder J.M., Lubar J.F., Monastra V.J., Miller D., Lubar J.O., Chen T.J., Comings D.E. Reward deficiency syndrom: a biogenetic model for the diagnosis and treatment of impulsive, addictive and compulsive behaviours // J. Psychoactive Drugs. 2000. V. 32. P. 1-112.
14. Brown E.S., Rush A.J., McEwen B.S. Hippocampal remodeling and damage by corticosteroids: implications for mood disorders // Neuropsychopharmacology. 1999. V. 21. No 4. P. 474-484.
15. Campbell S., Macqueen G. The role of the hippocampus in the pathophysiology of major depression // J. Psychiatry Neurosci. 2004. V. 29. No 6. P. 417-426.
16. Carlezon W.A., Jr, Duman R.S., Nestler E.J. The many faces of CREB // Trends Neurosci. 2005. V. 28. P. 436-445.
17. Chen B., Dowlatshahi D., MacQueen G.M., Wang J.F., Young L.T. Increased hippocampal BDNF immunoreactivity in subjects treated with antidepressant medication // Biol. Psychiatry. 2001. V. 50. P. 260-265.
18. Chen B., Shirayama Y., Shin K.H., Neve R.L., Duman R.S. Expression of the cAMP response element binding protein (CREB) in hippocampus produces an antidepressant effect // Biol. Psychiatry. 2001. V. 49. P. 753-762.
19. Coppen A., Wood K. Five-hydroxytriptamine in the pathogenesis of affective disorders // Adv. Biochem. Psychopharmacol. 1982. V. 34. P. 249-258.
20. Cotter D., Mackay D., Chana G., Beasley C., Landau S., Everall I.P. Reduced neuronal size and glial cell density in area 9 of the dorsolateral prefrontal cortex in subjects with major depressive disorder // Cereb. Cortex. 2002. V. 12. No 4. P. 386-394.
21. Dackis C.A., Gold M.S. New concepts in cocaine addiction: the dopamine depletion hypothesis // Neurosci.Biobehav.Rev. 1985. V. 9. P. 467-469.
22. Davis M., Hitchcock J.M., Bowers M.B., Berridge C.W., Melia K.R., Roth R.H. Stress-induced activation of prefrontal cortex dopamine turnover: blockade by lesions of the amygdala // Brain Res. 1994. V. 664. No 1-2. P. 207-210.
23. Dowlatshahi D., MacQueen G.M., Wang J.E., Young L.T. Increased temporal cortex CREB concentrations and antidepressant treatment in major depression // Lancet. 1998. V. 352. P. 1754-1755.
24. Dremencov E., Newman M.E., Konor N., Blatman-Jan G., Schindler C.J., Overstreet D.H., Yadid G. Hyperfunctionallity of serotonin-2C receptor-mediated inhibition of accumbal dopamine release in an animal model of depression is reversed by antidepressant treatment // Neuropharmacology. 2005. V. 48. No 1. P. 34-42.
25. Drevets W.C. Functional anatomical abnormalities in limbic and prefrontal cortical structures in major depression // Prog. Brain Res. 2000. V. 126. P. 413-431.
26. Duman R.S., Nakagawa S., Malberg J. Regulation of adult neurogenesis by antidepressant treatment // Neuropsychopharmacology. 2001. V. 25. P. 836-844.
27. Dunn A.J., Berridge C.W. Physiological and behavioral responses to corticotropin-releasing factor administration: is CRF a mediator of anxiety or stress responses? // Brain Res. Brain Res. Rev. 1990. V. 15. No 2. P. 71-100.
28. Elliott R., Sahakian B.J., Herrod J.J., Robbins T.W., Payke E.S. Abnormal response to negative feedback in unipolar depression: evidence for a diagnosis specific impairment // J. Neurol. Neurosurg. Psychiatry. 1997. V. 63. No 1. P. 74-82.
29. Ellwart T., Rinck M., Becker E.S. Selective memory and memory deficits in depressed inpatients // Depress. Anxiety. 2003. V. 17. No 4. P. 197-206.
30. Espiritu D.A., Rashid H., Mast B.T., Fitzgerald J., Steinberg, J., Lichtenberg P.A. Depression, cognitive impairment and function in Alzheimer's disease // Int. J. Geriatr. Psychiatry. 2001. V. 16. No 11. P. 1098-1103.
31. Fennig S., Mottes A., Ricter-Levin G., Treves J., Levkovitz Y. Everyday memory and laboratory memory tests: general function predictors in schizophrenia and remitted depression // J. Nerv. Ment. Dis. 2002. V. 190. No 10. P. 677-682.
32. Freis E.D. Mental depression in hypertensive patients treated for long periods with large doded of reserpine // N. Engl. J. Med. 1954. V. 251. P. 1006-1008.
33. Fuchs E., Gould E. Mini-review: in vivo neurogenesis in the adult brain: regulation and functional implications // Eur.J.Neurosci. 2000. V. 12. P. 2211-2214.
34. Gerrits M.A.F.M., Petromilli P., Westenberg H.G.M., Di Chiara G., van Ree J.M. Decrease in basal dopamine levels in the nucleus accumbens shell during daily drug-seeking behaviour in rats // Brain Res. 2002. V. 924. P. 141-150.
35. Gray T.S., Bingaman E.W. The amygdala: corticotropin-releasing factor, steroids, and stress // Crit. Rev. Neurobiol. 1996. V. 10. No 2. P. 155-168.
36. Gray J.A., McNaughton N. The Neuropsychology of Anxiety // Second Edition. Oxford: Oxford Med. Publ., 2000. 424 p.
37. Gregus A., Wintink A.J., Davis A.C., Kalynchuk L.E. Effect of repeated corticosterone injections and restraint stress on anxiety and depression-like behavior in male rats // Behav. Brain Res. 2005. V. 156. No 1. P. 105-114.
38. Gresch P.J., Sved A.F., Zigmond M.J., Finlay J.M. Local influence of endogenous norepinephrine on extracellular dopamine in rat medial prefrontal cortex // J. Neurochem. 1995. V. 65. No 1. P. 111-116.
39. Grigoryan G.A., Hodges H., Mitchell S., Sinden J., Gray J.A. 6-OHDA lesions of the Nucleus accumbens accentuate memory deficits in animals with lesions to the forebrain cholinergic projection system: effects of nicotine administration on learning and memory in the water maze // Neurobiol. Learning and Memory. 1996. V. 65. P. 135-153.
40. Grigoryan G.A., Mitchell S., Hodges H., Sinden J., Gray J.A. Are the cognitive enhancing effects of nicotine in the rats with lesion to the forebrain cholinergic projection system mediated by an interaction with the noradrenergic system? // Pharmacol. Biochem. Behav. 1994. V. 49. No 3. P. 511-521.
41. Heun R., Heun S. Risk factors of major depression in the elderly // Eur. Psychiatry. 2005. V. 20. No 3. P. 199-204.
42. Hong K.W., Lee W.S., Rhim B.Y. Role of central alpha 2-adrenoreceptors on the development of muricidal behavior in olfactory bulbectomized rats: effect of alpha 2-adrenoreceptor antagonists // Physiol. Behav. 1987. V. 39. P. 535-539.
43. Huether G., Zhou D., Ruther E. Long-term modulation of presynaptic serotonin input: experimentally induced changes in cortical serotonin transporter density, tryptophan hydroxilase and serotonin innervation density // J. Neur. Trans. 1997. V. 104. P. 993-1004.
44. Hui Z., Guang-Yu M., Chong-Tao X., Quan Y., Xiao-Hu X. Phenytoin reverses the chronic stress-induced impairment of memory consolidation for water maze training and depression of LTP in rat hippocampal CA1 region, but does not affect motor activity // Cogn. Brain Res. 2005. V. 24. P. 380-385.
45. Imaki T., Nahan J.L., Rivier C., Sawchenko P.E., Vale W. Differential regulation of corticotropin-releasing factor mRNA in rat brain regions by glucocorticoids and stress // J. Neurosci. 1991. V. 11. No 3. P. 585-599.
46. Jahnes E., Muller D.J., Schulze T.G., Windermuth C., Cichon S., Ohlraun S., Fangerau H., Held T., Maier W., Propping P., Nothen M.M., Rietschel M. Association study between two variants in the DOPA decarboxylase gene in bipolar and unipolar affective disorder // Neuropsychiatric Genetics. 2002. V. 114. No 5. P. 519-522.
47. Jay T. Dopamine: a potential substrate for synaptic plasticity and memory mechanisms // Progr. Neurobiol. 2003. V. 69. P. 375-390.
48. Jay T.M., Rocher C., Hotte M., Naudon L., Garden H., Spedding M. Plasticity at hippocampal to prefrontal cortex synapses is impaired by loss of dopamine and stress: importance for psychiatric diseases // Neurotox. Res. 2004. V. 6. No 3. P. 233-244.
49. Joss J.D., Burton R.M., Keller C.A. Memory loss in a patient treated with fluoxetine // Ann. Pharmacother. 2003. V. 37. No 12. P. 1800-1803.
50. Kalia M. Neurobiological basis of depression: an update // Metabolism Clin, and Exper. 2005. V. 54. P. 24-27.
51. Keck M.E., Sartori S.B., Welt T., Muller M.B., Ohl F., Holsboer F., Landgraf R., Singewald N. Differences in serotoninergic neurotransmission between rats displaying high or low anxiety/depression-like behaviour: effects of chronic paroxetine treatment // J. Neurochem. 2005. V. 92. No 5. P. 1170-1179.
52. Koob G.F. Neurobiology of addiction // Ann.N.Y. Acad.Sci. 2000. V. 909. P. 170-185.
53. Kuzis G., Sabe L., Tiberti C., Leiguarda R., Starkstein S.E. Cognitive functions in major depression and Parkinson disease // Arch. Neurol. 1997. V. 54. No 8. P. 982-986.
54. Lara C.L., Dumais A., Rouleau G., Lesage A., Dumont M., Chawky N., Aida M., Benkelfat C., Turecki G. STin2 variant and family history of suicide as significant predictors of suicide completion in major depression // Biol. Psychiatry. 2006. V. 59. No 2. P. 114-120.
55. MacQueen G.M., Campbell S., McEwen B.S., MacDonald K., Amano S., Joffe R.T. Course of illness. Hippocampal function and hippocampal volume in major depression // Proc.Nat.Acad.Sci. USA. 2003. V. 100. P. 1387-1392.
56. Maier S.F., Watkins L.R. Stressor controllability and learned helplessness: The roles of the dorsal raphe nucleus, serotonin, and corticotropin-releasing factor // Neurosci. Biobehav. Rev. 2005. V. 29. No 4-5. P. 829-841.
57. Mamalaki E., Kvetnansky R., Brady L.S., Gold P.W., Herkham M. Repeated immobilization stress alters tyrosine hydroxylase, corticotropin- releasing hormone and corticosteroid receptor messenger ribonucleic acid levels in rat brain // J. Neuroendocrinol. 1992.V. 4. P. 689-699.
58. McEwen B.S. Glucocorticoids, depression, mood disorders: structural remodeling in the brain // Metabol. Clin.and Exper. 2005. V. 54. P. 20-23.
59. McEwen B.S., Olie J.P. Neurobiology of mood, anxiety, and emotions as revealed by studies of a unique antidepressant: tianeptine // Mol. Psychiatry. 2005. V. 10. No 6. P. 525-537.
60. McKittrick C.R., Magarinos A.M., Blanchard R.J., McEwen B.S., Sakai R.R. Chronic social stress reduces dendritic arbors in CA3 of hippocampus and decreases binding to serotonin transporter sites // Synapse. 2000. V. 36. No 2. P. 85-94.
61. Meany M.J., Brake W., Gratton A. Environmental regulation of the development of mesolimbic dopamine systems: a neurobiological mechanism for vulnerability to drug abuse? // Psychoneuroendocrinology. 2002. V. 27. No 1-2. P. 127-138.
62. Mega M.S., Cummings J.L., Fiorello T., Gornbein J. The spectrum of behavioral changes in Alzheimer's disease // Neurology. 1996. V. 46.No 1.P.130-135.
63. Meltzer H.Y., Lowy M.T. The serotonin hypothesis of depression // Psychopharmacology: The Third Generation of Progress / Ed. Meltzer H.Y. N.Y.: Raven Press, 1987. P. 513-526.
64. Naudon L., Jay T.M. Opposite behaviours in the forced swimming test are linked to differences in spatial working memory performances in the rat // Neuroscience. 2005. V. 130. No 2. P.285-293.
65. 65. Nestler E.J., Barrot M., DiLeone R.J., Eisch A.J., Gold S.J., Monteggia L.M. Neurobiology of depression // Neuron. 2002. V. 34. No 1. P. 13-25.
66. Nibuya M., Morinobu S., Duman R.S. Regulation of BDNF and trkB mRNA in rat brain by chronic electroconvulsive seizure and antidepressant drug treatments // J. Neurosci. 1995. V. 15. P. 7539-7547.
67. Patel J.G., Bartoszyk G.D., Edwards E., Ashby C.R., Jr. The highly selective 5-hydroxytryptamine (5HT)2A receptor antagonist, EMD 281014, significantly increases swimming and decreases immobility in male congenital learned helpless rats in the forced swim test // Synapse. 2004. V. 52. No 1. P. 73-75.
68. Phillips A.G., Pfaus J.G., Blaha C.D. Dopamine and motivated behavior: insights provided in vivo analysis // The Mesolimbic Dopamine System: From Motivation to Action / Eds Willner P., Scueel-Kruger J. Chichester, UK: Willey, 1991. P. 199-224.
69. Pliakas A.M., Carlson R.R., Neve R.L., Konradi C., Nestler E.J., Carlezon W.A. Altered responsiveness to cocaine and increased immobility in the forced swim test associated with elevated CREB expression in the nucleus accumbens // J. Neurosci. 2001. V. 21. P. 7397-7403.
70. Polidori M.C., Menculinin G., Senin U., Mecocci P. Dementia, depression and parkinsonism: A frequent association in the elderly // J. Alzheimers Dis. 2001. V. 3. No 6. P.553-562.
71. Porsolt R.D., Anton G., Blavet N., Jalfre M. Behavioural despair in rats: a new model sensitive to antidepressant treatments // Eur. J. Pharmacol. 1978. V. 47. No 4. P. 379-391.
72. Pryce C.R., Ruedi-Bettschen D., Dettling A.C., Weston A., Russig H., Ferger B., Feldon J. Long-term effects of early-life environmental manipulations in rodents and primates: Potential animal models in depression research // Neurosci. Biobehav. Rev. 2005. V. 29. No 4-5. P. 649-674.
73. Pryor J.C., Sulser F. Evolution of the monoamine hypothesis of depression // Biological Aspects of Affective Disorders / Eds Horton R.W., Katona C.L.E. N.Y.: Acad. Press, 1991. P. 77-94.
74. Rajkowska G. Depression: what we can learn from postmortem studies // Neuroscientist. 2003. V. 9. No 4. P. 273-284.
75. Redmond A.M., Kelly J.P., Leonard B.E. Behavioral and neurochemical effects of dizocilpine in the olfactory bulbectomized rat model of depression // Pharmacol. Biochem. Behav. 1997. V. 58. P. 355-359.
76. Reid I.C., Stewart C.A. How antidepressant work // Br. J. Psychol. 2001. V. 178. P. 299-303.
77. Rice F., Harold J.T., Thapar A. The link between depression in mothers and offspring: an extended twin analysis // Behav. Genet. 2005. V. 35. No 5. P. 565-577.
78. Rocher C., Spedding M., Munoz C., Jay T.M. Acute stress-induced changes in hippocampal / prefrontal circuits in rats: effects of antidepressants // Cereb. Cortex. 2004. V. 14. No 2. P. 224-229.
79. Rossetti Z.L., Hmaidan Y., Gessa G.L. Marked inhibition of mesolimbic dopamine release: a common feature of ethanol, morphine, cocaine and amphetamine abstinence in rats // Eur. J. Pharmacol. 1992. V. 221. P. 227-234.
80. Salamone J.D., Cousins M.S., Snyder B.J. Behavioral functions of nucleus accumbens dopamine: empirical and conceptual problems with the anhedonia hypothesis // Neurosci. Biobehav. Rev. 1997. V. 21. No 3. P. 341-359.
81. Sallivan R.M., Gratton A. Relationships between stress-induced increases in medial prefrontal cortical dopamine and plasma corticosterone levels in rats: role of cerebral laterality // Neuroscience. 1998. V. 83. No 1.P.81-91.
82. Sapolsky R.M. Glucocorticoids and hippocampal atrophy in neuropsychiatric disorders // Arch. Gen. Psychiatry. 2000. V. 57. P. 925-935.
83. Schultz W. Multiple reward signals in the brain // Nat.Rev.Neurosci. 2000. V. 1. P. 199-207.
84. Sheline Y.I., Gabo M.H., Kraemer H.C. Untreated depression and hippocampal volume loss // Am. J. Psychiatry. 2003. V. 160. No 8. P. 1516-1518.
85. Smagin G.N., Swiergiel A.H., Dunn A.J. Corticotropin-releasing factor administered into the locus coeruleus, but not the parabrachial nucleus, stimulates norepinephrine release in the prefrontal cortex // Brain Res. Bull. 1995. V. 36. P. 71-76.
86. Smith M.A., Makino S., Kvetnansky R., Post R.M. Stress and glucocorticoids affect the expression of brain-derived neurotrophic factor and neurotrophin-3 mRNAs in the hippocampus // J. Neurosci. 1995. V. 15. P. 1768-1777.
87. Song C., Leonard B.E. The olfactory bulbectomised rat as a model of depression // Neurosci. Biobehav. Rev. 2005. V. 29. No 4-5. P. 627-647.
88. Song C., Leonard B.E. The effects of olfactory bulbectomy in the rat, alone or in combination with antidepressants and endogenous factors, an immune function // Hum.Psychopharmacol. 1995. V. 10. P. 7-18.
89. Stewart C., Jeffery K., Reid I. LTP-like synaptic efficacy changes following electroconvulsive stimulation // Neuroreport. 1994. V. 5. P. 1041-1044.
90. Stewart C.A., Reid I.C. Repeated ECS and fluoxetine administration have equivalent effects on hippocampal synaptic plasticity // Psychopharmacology. 2000. V. 148. No 3. P. 217-223.
91. Stewart R.J., Chen B., Dowlatchahi D., MacQueen G.M., Young L.T. Abnormalities in the camp signaling pathway in postmortem brain tissue from the Stanley Neuropathology Consortium // Brain Res. Bull. 2001. V. 55. P. 625-629.
92. Sun M.-K., Alkon D.L. Induced depressive behavior impairs learning and memory in rats // Neuroscience. 2004. V. 129. No 1. P. 129-139.
93. Sun M.-K., Alkon D.L. Dual effects of bryostatin-1 on spatial memory and depression // Eur. J. Pharmacol. 2005. V. 512. No. 1. P.43-51.
94. Tzschentke T.M. The medial prefrontal cortex as a part of the brain reward system // Amino Acids. 2000. V. 19. No 1. P. 211-219.
95. Uekermann J., Daum I., Peters S., Wiebel B., Przuntek H., Muller T. Depressed mood and executive dysfunction in early Parkinson's disease // Acta Neurol. Scand. 2003. V. 107. No 5. P. 341-348.
96. Vaidya V.A., Marek G.J., Aghajanian G.K., Duman R.S. 5-HT2A receptor-mediated regulation of brain-derived neurotrophic factor mRNA in the hippocampus and the neocortex // J. Neurosci. 1997. V. 17. P. 2785-2795.
97. Valentino R.J., Van Bockstaele E. Opposing regulation of the locus coeruleus by corticotropin-releasing factor and opioids. Potential for reciprocal interactions between stress and opioid sensitivity // Psychopharmacology. 2001. V. 158. P. 331-342.
98. Yadid G., Overstreet D.H., Zangen A. Limbic dopaminergic adaptation to a stressful stimulus in a rat model of depression // Brain Res. 2001 V. 896. No 1-2. P. 43-47.
99. You Z.B., Chen Y.O., Wise R.A. Dopamine and glutamate release in the nucleus accumbens and ventral tegmental area of rat following lateral hypothalamic self- stimulation // Neuroscience. 2001. V. 107. No 4. P. 629-639.
100. Young L.T., Bakish D., Beaulieu S. The neurobiology of treatment response to antidepressants and mood stabilizing medications // J. Psychiatry Neurosci. 2002. V. 27. P. 260-265.